Tango Therapeutics Inc (TNGX)
3.90
+0.34
(+9.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.90
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Shareholders Equity (Quarterly): 229.17M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 229.17M |
| June 30, 2024 | 247.67M |
| March 31, 2024 | 264.45M |
| December 31, 2023 | 253.11M |
| September 30, 2023 | 276.60M |
| June 30, 2023 | 212.94M |
| March 31, 2023 | 227.26M |
| Date | Value |
|---|---|
| December 31, 2022 | 249.48M |
| September 30, 2022 | 273.07M |
| June 30, 2022 | 298.70M |
| March 31, 2022 | 320.36M |
| December 31, 2021 | 344.75M |
| September 30, 2021 | 365.41M |
| December 31, 2020 | 38.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
38.60M
Minimum
Dec 2020
365.41M
Maximum
Sep 2021
257.26M
Average
258.78M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.42M |
| Total Liabilities (Quarterly) | 123.24M |
| Current Ratio | 8.004 |